254 related articles for article (PubMed ID: 25098025)
41. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
[TBL] [Abstract][Full Text] [Related]
42. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.
Checa MA; Prat M; Robles A; Carreras R
Fertil Steril; 2006 Mar; 85(3):573-7. PubMed ID: 16500321
[TBL] [Abstract][Full Text] [Related]
43. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women.
Hedon B; Hugues JN; Emperaire JC; Chabaud JJ; Barbereau D; Boujenah A; Howles CM; Truong F
Hum Reprod; 1998 Oct; 13(1O):2688-92. PubMed ID: 9804214
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
[TBL] [Abstract][Full Text] [Related]
45. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy.
Ho Yuen B; Pride SM; Sime MO
Am J Obstet Gynecol; 1984 Mar; 148(5):508-12. PubMed ID: 6422760
[TBL] [Abstract][Full Text] [Related]
46. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study.
Hugues JN; Cédrin-Durnerin I; Howles CM; ; Amram M; Angelini A; Balen A; Barbereau D; Birkhauser M; Boujenah A; De Leo V; De Placido G; Dessole S; Favrin S; Ferrazi E; Gay C; Germond M; Hedon B; Hocke C; Jolly C; Lamarca-Roth E; Lanzone A; Marchand F; Marcolin G; Mascaretti G; Moreau L; Massobrio M; Nappi C; Pardi G; Pennehouat G; Porcu E; Seibert M; Selvaggi L; Thiers D; Venturini P
Hum Reprod; 2006 Nov; 21(11):2817-22. PubMed ID: 16877376
[TBL] [Abstract][Full Text] [Related]
47. Ovulation induction with minimal dose of follitropin alfa: a case series study.
Bruna-Catalán I; Menabrito M;
Reprod Biol Endocrinol; 2011 Oct; 9():142. PubMed ID: 22024419
[TBL] [Abstract][Full Text] [Related]
48. Pregnancy after treatment with three recombinant gonadotropins.
Agrawal R; West C; Conway GS; Page ML; Jacobs HS
Lancet; 1997 Jan; 349(9044):29-30. PubMed ID: 8988125
[No Abstract] [Full Text] [Related]
49. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization.
Lisi F; Rinaldi L; Fishel S; Caserta D; Lisi R; Campbell A
Fertil Steril; 2005 Feb; 83(2):309-15. PubMed ID: 15705367
[TBL] [Abstract][Full Text] [Related]
51. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
52. Optimizing the gonadotrophin dose regimen.
Out HJ; Thomas LE
Int Surg; 2006; 91(5 Suppl):S15-24. PubMed ID: 17436601
[TBL] [Abstract][Full Text] [Related]
53. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study.
Blockeel C; De Vos M; Verpoest W; Stoop D; Haentjens P; Devroey P
Hum Reprod; 2009 Nov; 24(11):2910-6. PubMed ID: 19617207
[TBL] [Abstract][Full Text] [Related]
54. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z
Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024
[TBL] [Abstract][Full Text] [Related]
55. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
[TBL] [Abstract][Full Text] [Related]
56. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
Balen AH; Platteau P; Andersen AN; Devroey P; Sørensen P; Helmgaard L; Arce JC
BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
[TBL] [Abstract][Full Text] [Related]
57. Individualised gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: A prospective, observational study.
Lauritsen MP; Loft A; Pinborg A; la Cour Freiesleben N; Cohen A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():76-82. PubMed ID: 27960134
[TBL] [Abstract][Full Text] [Related]
58. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study.
Matorras R; Prieto B; Exposito A; Mendoza R; Crisol L; Herranz P; Burgués S
Reprod Biomed Online; 2009 Dec; 19(6):879-87. PubMed ID: 20031032
[TBL] [Abstract][Full Text] [Related]
59. Early versus late hCG administration to trigger ovulation in mild stimulated IUI cycles: a randomized clinical trial.
da Silva AL; Arbo E; Fanchin R
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):156-60. PubMed ID: 22743137
[TBL] [Abstract][Full Text] [Related]
60. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
